Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: this is a 68-year old female with a history of myelodysplastic syndrome transformed into acute myelogenous leukemia (type m6a) diagnosed one month ago who was initially admitted for treatment with low-dose ara-c and hydroxyurea. her disease was initially diagnosed secondary to pancytopenia with circulating blast forms and a bone marrow in . she was initially treated with procrit and weekly transfusions with packed red blood cells and danazol from which she developed an allergic reaction. over the last week prior to admission, she developed increased fatigue. repeat bone marrow showed 7 percent to 10 percent myeloblasts. past medical history: as above, history of myelodysplastic syndrome transformed into acute myelogenous leukemia. no prior surgeries or prior hospitalizations. medications on admission: procrit 40,000 units every week and tylenol as needed. allergies: danazol (causes facial swelling and periorbital edema). social history: a 70-pack-year smoking history; currently smokes half a pack per day. three drinks of alcohol per night. she is a retired office manager. family history: sister deceased from a central nervous system aneurysm. brother deceased from coronary artery disease. she has one daughter and one son. summary of hospital course: 1. hematology/oncology issues: the patient was initially admitted on to the bone marrow transplant service. she was treated with 13 days of low-dose ara-c as well as hydroxyurea. she was treated initially with a one time dose of gm-csf which was then discontinued secondary to fevers. the patient did not show any signs of tumor lysis by laboratories. currently waiting for counts to recover. 1. febrile neutropenia issues: the patient had fevers up to 103 as well as neutropenia. she was originally started on cefepime, fluconazole, and vancomycin. the cefepime was discontinued and switched to aztreonam because of a diffuse rash. ambisome was eventually started for continued fevers, but then discontinued secondary to acute renal failure and switched to voriconazole. vancomycin levels have been very elevated and was being dosed by levels. the blood cultures have remained negative to date. a chest x-ray did not show any infiltrates. urine cultures from grew 10:100,000 enterococcus with sensitivities pending. the patient was empirically started on linezolid, and the vancomycin was discontinued. 1. gastrointestinal bleed issues: in the setting of thrombocytopenia, the patient developed melanotic stools on the bone marrow transplant floor. she remained hemodynamically stable and was transferred the intensive care unit for better monitoring. her platelets were kept above 50 and her hematocrit above 25. she continued to have a slow gastrointestinal bleed. gastroenterology was consulted and is following, holding off on colonoscope at this time. she given vitamin k, as well as amicrobic acid, and protonix twice per day. she requires hla typed and matched platelets secondary to antibodies. 1. hypotension issues: the patient developed hypotension with mean arterial pressures in the 40s; asymptomatic. she was given multiple boluses of intravenous fluids without significant improvement in her pressures. the differential diagnoses included sepsis, gastrointestinal bleed, excessive losses from fever and rash as well as capillary leak syndrome. she was started on low-dose dopamine for renal perfusion. 1. acute renal failure issues: the patient developed acute renal failure with a creatinine of up to 3.2. the renal service was consulted. urine sediment showed muddy brown casts. the likely insult was hypotension in the setting of a gastrointestinal bleed. the patient continues to oliguric with improvement in the urine output with a low- dose dopamine drip. urine also showed eosinophils - possible acute interstitial nephritis from multiple drugs. the patient was started on a trial of prednisone. the patient was also started on bicitra 30 twice per day. 1. pulmonary issues: the patient was continued on albuterol and atrovent nebulizers for chronic obstructive pulmonary disease seen on computerized axial tomography with a longstanding history of smoking. 1. rash issues: the patient developed a diffuse erythematous blanching rash which was likely secondary to drug effect - cefepime versus vancomycin. the dermatology service was consulted, and a biopsy was consistent with hypersensitivity reaction. the patient was started clobetasol and bacitracin topically as well as sarna lotion for pruritus. 1. fluids/electrolytes/nutrition issues: the patient was continued on a full liquid diet. electrolytes were repleted once per day. she was maintained on maintenance fluids. 1. prophylaxis issues: proton pump inhibitor and bowel regimen. 1. access issues: hickman catheter and peripheral lines. 1. contact issues: son and daughter. 1. code status issues: do not resuscitate/do not intubate. the rest of the hospital course will be dictated by the next intensive care unit intern. , procedure: venous catheterization, not elsewhere classified transfusion of packed cells closed biopsy of skin and subcutaneous tissue injection or infusion of cancer chemotherapeutic substance injection or infusion of oxazolidinone class of antibiotics venous catheterization, not elsewhere classified transfusion of packed cells closed biopsy of skin and subcutaneous tissue injection or infusion of cancer chemotherapeutic substance injection or infusion of oxazolidinone class of antibiotics diagnoses: urinary tract infection, site not specified congestive heart failure, unspecified acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified blood in stool diastolic heart failure, unspecified acute myeloid leukemia, without mention of having achieved remission 

Answer: The patient is high likely exposed to